Intravascular ultrasound assessment of the mechanisms and predictors of restenosis following coronary angioplasty

Journal of Invasive Cardiology

Volumn 8, Issue 1, 1996, Pages 1-14

  Mintz, Gary S ^a   Popma, Jeffrey J ^a   Pichard, Augusto D ^a   Kent, Kenneth M ^a   Satler, Lowell F ^a   Hong, Mun K ^a   Leon, Martin B ^a,b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Angioplasty; Arterial remodeling; Atherectomy; Intravascular ultrasound; Quantitative angiography; Restenosis

Indexed keywords

EID: 0002447368     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (135)

1. Holmes D, Vlietstra R, Smith H, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): Areport from the PTCA Registry of the NHLBI. Am J Cardiol 1984;53:77C-81C.
2. Detre K, Holubkov R, Kelsey S, et al. Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. N Engl J Med 1988;318:265-270.
3. Serruys P, Luijten H, Beatt K, et al. Incidence of restenosis after successful coronary angioplasty: A time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation 1988;77:361-371.
4. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-623.
5. Califf R, Fortin D, Frid D, et al. Restenosis after coronary angioplasty: An overview. J Am Coll Cardiol 1991;17:2B-13B.
6. Reidy M, Fingerle J, Lindner V. Factors controlling the development of arterial lesions after injury. Circulation 1992;86:III-43-III-46.
7. Gertz S, Gimple L, Banai S, et al. Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty: Evidence from correlative angiographic-histomorphometric studies of atherosclerotic arteries in rabbits. Circulation 1994;94:3001-3008.
8. Schwartz R, Huber K, Murphy J, et al. Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992;19:267-274.
9. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 1990;82:2190-2200.
10. Muller D, Ellis S, Topol E. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992;19:418-432.
11. Steele P, Chesebro J, Stanson A, et al. Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985;57:105-112.
12. Austin G, Ratliff N, Hollman J, et al. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;6:369-375.
13. Essed C, Van Den Brand M, Becker A. Transluminal coronary angioplasty and early restenosis: Fibrocellular occlusion after wall laceration. Br Heart J 1983;49:393-396.
14. Bruneval P, Guermoprez J, Perrier P, et al. Coronary artery restenosis following transluminal coronary angioplasty. Arch Pathol Lab Med 1986;110:1186-1187.
15. Farb A, Virmani R, Atkinson J, Kolodgie F. Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty. J Am Coll Cardiol 1990;16:1421-1429.
16. Garratt K, Edwards W, Vlietstra R, et al. Coronary morphology after percutaneous directional coronary atherectomy in humans: Autopsy analysis of three patients. J Am Coll Cardiol 1990;16:1432-1436.
17. Ueda M, Becker A, Fujimoto T. Pathologic changes induced by repeated percutaneous transluminal coronary angioplasty. Br Heart J 1987;58:635-643.
18. Gravarus M, Roubin G. Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: The problem of restenosis. Hum Pathol 1989;20:477-485.
19. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 1991;17:433-439.
20. Giraldo A, Esposo O, Meis J. Intimal hyperplasia as a cause of restenosis after percutaneous transluminal coronary angioplasty. Arch Pathol Lab Med 1985;109:173-175.
21. Kohchi K, Takebayashi S, Block PC, et al. Arterial changes after percutaneous transluminal coronary angioplasty: Results at autopsy. J Am Coll Cardiol 1987;10:592-599.
22. Morimoto S, Mizuno Y, Hiramitsu S, et al. Restenosis after percutaneous transluminal coronary angioplasty: A histopathologic study using autopsied hearts. Jpn Circ J 1990;5:43-56.
23. Johnson D, Hinohara T, Selmon M, et al. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: A histopathologic study. J Am Coll Cardiol 1990;15:419-425.
24. Safian R, Gelbfish J, Erny R, et al. Coronary atherectomy. Clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation 1990;82:69-79.
25. Garratt KN, Edwards WD, Kaufmann UP, et al. Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: Analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 1991;17:442-448.
26. Strauss B, Umans V, van Suylen R-J, et al. Directional atherectomy for treatment of restenosis within coronary stents: Clinical, angiographic and histologic results. J Am Coll Cardiol 1992;20:1465-1473.
27. Riessen R, Isner J, Blessing E, et al. Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic coronary arteries. Am J Pathol 1994;144:962-974.
28. Isner J, Kearney M, Bortman S, et al. Sequential biopsy of human atheromata in vivo: Longitudinal analysis of atheromatous coronary arterial wall in 11 patients treated for primary and restenosis lesions by directional atherectomy. J Am Coll Cardiol 1993;21:74A.
29. Dartsch P, Voisard R, Bauriedel G, et al. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing lesions. Arteriosclerosis 1990;10:62-75.
30. Pickering J, Weir L, Rosenfield K, et al. Smooth muscle cell outgrowth from human atherosclerotic plaque. Implications for the assessment of human biology. J Am Coll Cardiol 1992;20:1430-1439.
31. Bauriedel G, Windstetter U, DeMaio SJJ, et al. Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy. Circulation 1992;85:554-564.
32. Pickering J, Weir L, Jekanowski J, et al. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993;91:1469-1480.
33. Forrester J, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J Am Coll Cardiol 1991;17:758-769.
34. Ellis SG, Muller DWM. Arterial injury and the enigma of coronary restenosis. J Am Coll Cardiol 1992;19:275-277.
35. Liu M, Roubin G, King SI. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989;79:1374-1387.
36. Glagov S. Intimal hyperplasia, vascular remodeling, and the restenosis problem. Circulation 1994;89:2888-2891.
37. Franklin S, Faxon D. Pharmacologic prevention of restenosis after coronary angioplasty: Review of randomized clinical trials. Cor Artery Dis 1993;4:232-242.
38. Lambert M, Bonan R, Cote G, et al. Multiple coronary angioplasty: A model to discriminate systemic and procedural factors related to restenosis. J Am Coll Cardiol 1988;12:310-314.
39. Leimgruber P, Roubin G, Hollman J, et al. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation 1986;73:710-717.
40. Galan K, Deligonul U, Kern M, et al. Increased frequency of restenosis in patients continuing to smkoe cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988;61:260-263.
41. Austin G, Lynn M, Hollman J. Laboratory test results as predictors of recurrent coronary artery stenosis following angioplasty. Arch Pathol Lab Med 1987:1158-1162.
42. Weintraub W, Kosinski A, Brown CI, King SI. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993;21:6-14.
43. Reis G, Kuntz R, Silverman D, Pasternak R. Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol 1991;68:1431-1435.
44. Kahn J, Rutherford B, McConahay D, et al. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J 1990;119:484-489.
45. Hirshfeld JW, Schwartz JS, Jugo R, et al. Restenosis after coronary angioplasty: A multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 1991;18:647-656.
46. Kuntz RE, Gibson CM, Nobuyoshi M, Baim DS. Generalized model of restenosis after conventional balloon angioplasty and new devices. J Am Coll Cardiol 1993;21:15-25.
47. Nichols A, Smith R, Berke A, Shlomfitz R, Powers E. Importance of balloon size in coronary angioplasty. J Am Coll Cardiol 1989;13:1094-1100.
48. Vandormael M, Deligonul U, Kern M, et al. Multilesion coronary angioplasty: Clinical and angiographic follow-up. J Am Coll Cardiol 1987;10:246-252.
49. Roubin G, King SI, Douglas J, JR. Restenosis after percutaneous transluminal coronary angioplasty: The Emory University Hospital experience. Am J Cardiol 1987;60:39B-43B.
50. de Feyter PJ, Van Suylen R-J, de Jaegere PPT, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993;21:1539-1549.
51. Meier B. Total coronary occlusion: A different animal? J Am Coll Cardiol 1991;17:50B-57B.
52. Bourassa M, Lesperance J, Eastwood C, et al. Clinical physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1991;18:368-376.
53. Serruys P, Foley D, Kirkeeide R, King SI. Restenosis revisited: Insights provided by quantitative coronary angiography. Am Heart J 1993;126:1243-1267.
54. Serruys P, Foley D, De Feyter P. Restenosis after coronary angioplasty: A proposal of new comparative approaches based on quantitative angiography. British Heart J 1992;68:417-424.
55. Isner JM. Vascular remodeling. Honey, I think I shrunk the artery. Circulation 1994;89:2937-2941.
56. Currier J, Faxon D. Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-520.
57. Mintz G, Popma J, Pichard A, et al. Patterns of calcification in coronary artery disease. A statistical analysis of intravascular ultrasound and coronary angiography in 1155 lesions. Circulation 1995;91:1969-1965.
58. Mintz G, Painter J, Pichard A, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-1485.
59. Hodgson J, Reddy K, Suneja R, et al. Intracoronary ultrasound imaging: Correlation of plaque morphology with angiography, clinical syndrome and procedural results in patients undergoing coronary angioplasty. J Am Coll Cardiol 1993;21:35-44.
60. Tenaglia AN, Buller CE, Kisslo KB, et al. Mechanisms of balloon angioplasty and directional coronary atherectomy as assessed by intracoronary ultrasound. J Am Coll Cardiol 1992;20:685-691.
61. DeFranco A, Tuzcu E, Moliterno D, et al. Overestimation of lumen size after coronary intervention: Implications for randomized trials of new devices. Circulation 1994;90:I-550.
62. Potkin B, Keren G, Mintz G, et al. Arterial responses to balloon coronary angioplasty: An intravascular ultrasound study. J Am Coll Cardiol 1992;20:942-951.
63. Popma J, Bashore T. Qualitative and quantitative angiography. In: Topol E (ed). Textbook of Interventional Cardiology. Philadelphia: W. B. Saunders, 1994: pp. 1052-1068.
64. Tobis JM, Mallery J, Mahon D, et al. Intravascular ultrasound imaging of human coronary arteries in vivo. Analysis of tissue characterizations with comparison to in vitro histological specimens. Circulation 1991;83:913-926.
65. Potkin BN, Bartorelli AL, Gessert JM, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 1990;81:1575-1585.
66. Nissen SE, Grines CL, Gurley JC, et al. Application of a new phased-array ultrasound imaging catheter in the assessment of vascular dimensions. In vivo comparison to cineangiography. Circulation 1990;81:660-666.
67. Tobis J, Mallery J, Gessert J, et al. Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. Circulation 1989;80:873-882.
68. Nishimura R, Edwards W, Warnes C, et al. Intravascular ultrasound imaging: In vitro validation and pathologic correlation. J Am Coll Cardiol 1990;16:145-154.
69. Hodgson J, Graham S, Sarakus A, et al. Clinical percutaneous imaging of coronary anatomy using an over-the-wire ultrasound catheter system. In J Cardiac Imaging 1989;4:186-193.
70. Mallery JA, Tobis JM, Griffith J, et al. Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J 1990;119:1392-1400.
71. Mintz G, Potkin B, Keren G, et al. Intravascular ultrasound evaluation of the effect of rotational atherectomy in obstructive atherosclerotic coronary artery disease. Circulation 1992;86:1383-1393.
72. Kovach J, Mintz G, Pichard A, et al. Sequential intravascular ultrasound characterization of the mechanisms of rotational atherectomy and adjunct balloon angioplasty. J Am Coll Cardiol 1993;22:1024-1032.
73. Rasheed Q, Nair R, Sheehan H, Hodgson JM. Correlation of intracoronary ultrasound plaque characteristics in atherosclerotic coronary artery disease patients with clinical variables. Am J Cardiol 1994;73:753-758.
74. Pandian N, Kreis A, Weintraub A, Kumar R. Intravascular ultrasound assessment of arterial dissection, intimal flaps, and intraarterial thrombi. Am J Cardiol 1991;5:72-77.
75. Dixon WJ, Brown MB, Engelman L. BMDP Statistical Software Manual. Berkley, CA: University of California Press, 1990.
76. McBride W, Lange R, Hillis L. Restenosis after successful coronary angioplasty, pathopysiology and prevention. N Engl J Med 1988;318:1734-1737.
77. Ip J, Fuster V, Israel D, et al. The role of platelets, thrombin, and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991;17:77B-88B.
78. Haudenschild C. Pathogenesis of restenosis. Z Kardiol 1989;78:28-34.
79. Ferns G, Raines E, Sprugel K, et al. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF. Science 1991;253:1129-1132.
80. Chesebro J, Lam J, Badimon L, Fuster V. Restenosis after arterial angioplasty: A hemorrheologic response to injury. Am J Cardiol 1987;60:10B-16B.
81. Willerson J, Yao S, McNatt J, et al. Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sci USA 1991;88:10624-10628.
82. Fingerle J, Johnson R, Clowes A, et al. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 1989;86:8412-8416.
83. Okazaki H, Majesky M, Harker L, Schwartz S. Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ Res 1992;71:1285-1293.
84. Graham D, Alexander J. The effects of thrombin on bovine endothelial and smooth muscle cells. J Vasc Surg 1990;11:307-313.
85. Ross R. Platelet-derived growth factor. Lancet 1989;i:1179-1182.
86. Lindner V, Majack R, Reidy M. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990;85:2004-2008.
87. Lindner V, Reidy M. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against fibroblast growth factor. Proc Natl Acad Sci USA 1991;88:3739-3743.
88. Castellot J, Favreau L, Karnovsky M, Rosenberg R. Inhibition of vascular smooth muscle cell growth by endothelium cell-derived heparin. J Biol Chem 1982;257:11256-11260.
89. Clowes AW, Karnowsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977;265:625-626.
90. Majack R, Clowes A. Inhibition of vascular smooth muscle cell migration by heparin-like glycosaminoglycans. J Cell Physiol 1984;118:253-256.
91. Casscells W. Migration of smooth muscle and endothelial cells: Critical events in restenosis. Circulation 1992;86:723-729.
92. Clowes A, Reidy M, Clowes M. Mechanism of stenosis after arterial injury. Lab Invest 1983;49:208-215.
93. Clowes AW, Clowes MM. Kinetics of cellular proliferation after arterial injury. IV. Heparin inhibits rat smooth muscle mitogenesis and migration. Circ Res 1986;58:839-845.
94. Taubman M. Gene induction in vessel wall injury. Thrombosis and Haemostasis 1993;70:180-183.
95. Clowes A, Clowes M, Fingerle J, Reidy M. Regulation of smooth muscle cell growth in injured artery. J Cardiovasc Pharm 1989;14:S12-S15.
96. Schwartz R, Srivatsa S, Camrud A, Isner J. Smooth muscle cell proliferation in coronary restenosis is limited to a few generations: Cell kinetic model implications. J Am Coll Cardiol 1994;23:20A.
97. Libby P, Schwartz D, Brogi E, et al. A cascade model for restenosis: A special case of atherosclerosis progression. Circulation 1992;86:III-47-III-52.
98. Clowes A, Schwartz S. Significance of quiescent smooth muscle cell migration in the injured rat carotid artery. Circ Res 1985;56:139-145.
99. Ohara T, Nanto S, Asada S, et al. Ultrastrucrural study of proliferating and migrating smooth muscle cells at the site of PTCA as a explanation for restenosis. Circulation 1988;74:II-290.
100. Schwartz S, Heimark R, Majesky M. Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990;70:1177-1209.
101. Pickering J, Ford C, Novick R. Collagen elaboration following balloon angioplasty - Evidence for rapid expression and deposition. J Am Coll Cardiol 1994;23:235A.
102. Ip JH, Fuster V, Badimon L, et al. Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscles cell proliferation. J Am Coll Cardiol 1990;15:1667-1687.
103. Wight T. Cell biology of arterial proteoglycans. Arteriosclerosis 1989;9:1-20.
104. Waller BF, Garfinkel HJ, Rogers FJ, et al. Early and late morphological changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplasty. Am J Cardiol 1984;53:42C-47C.
105. Lee P, Gibbons G, Dzau V. Cellular and molecular mechanisms of coronary artery restenosis. Cor Art Dis 1993;4:254-259.
106. Thornton M, Gruentzig A, Hollman J, et al. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: A randomized study. Circulation 1984;69:721-727.
107. Whitworth H, Roubin G, Hollman J, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-1276.
108. O'Keefe J, McCallister B, Bateman T, et al. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992;19:1597-1600.
109. Van Erven L, Velema E, Bos A, Post M, Borst C. Thrombogenecity and intimal hyperplasia after conventional and thermal balloon dilatation in normal rabbit iliac arteries. J Vasc Res 1992;29:426-434.
110. Van Erven L, Post M, Velema E, Borst C. In the normal rabbit femoral artery increasing arterial wall injury does not lead to increased intimal hyperplasia. J Vasc Res 1994;31:153-162.
111. O'Brien E, Alpres C, Stewart D, et al. Proliferation in primary and restenotic coronary atherectomy specimens: Implications for antiproliferative therapy. Circ Res 1993;73:223-231.
112. Kakuta T, Currier J, Haudenschild C, et al. Differences in compensatory vessel enlargement, not intimal proliferation, account for restenosis after angioplasty in the hypercholesterolemic rabbit. Circulation 1994;89:2809-2815.
113. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. Circulation 1994;89:2816-2821.
114. Post M, van Erven L, Velema E, et al. Which part of the angiographic diameter reduction after balloon dilatation is due to intimal hyperplasia? J Am Coll Cardiol 1993;21:36A.
115. Lafont A, Guzman L, Whitlow P, et al. Restenosis after experimental angioplasty: Intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res 1995;76:996-1002.
116. Brott B, Labinaz M, Culp S, et al. Vessel remodeling after angioplasty: Comparative anatomic studies. Circulation 1994;1994:I-138.
117. Haudenschild C. Pathobiology of restenosis after angioplasty. Am J Med 1993;94(Suppl 4A):4A-40S-4A-44S.
118. Galis Z, Sukhova G, Lark M, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994;94:2493-2503.
119. Strauss B, Chisolm R, Keeley F, et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-658.
120. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of various human atherosclerotic arteries. N Engl J Med 1987;316:1371-1375.
121. Zarins C, Weisenberg E, Kolettis G, Stankunavicius R, Glagov S. Differential enlargement of artery segments in response to enlarging atherosclerotic plaques. J Vasc Surg 1988,7:386-394.
122. Kamiya A, Togawa T. Adaptive regulation of wall shear stress to flow change in the canine coronary artery. Am J Physiol 1980;239:H14-H21.
123. Zarins C, Zatina M, Giddens D, et al. Shear stress regulation of artery lumnen diameter in experimental atherogenesis. J Vasc Surg 1987;5:413-420.
124. Langille B, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium dependent. Science 1986;231:405-407.
125. Furchgott R. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-573.
126. Vane J, Anggard E, Botting R. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
127. Bond M, Adams M, Bullock B. Complicating factors in evaluating atherosclerosis. Artery 1981;9:21-29.
128. Langille B, Bendeck M, Keeley F. Adaptations of carotid arteries of young and mature rabbits to reduced carotid flow. Am J Physiol 1989;256:H931-H939.
129. Friedman M, Deters O, Bargeron C, et al. Shear-dependent thickening of the human arterial intima. Atherosclerosis 1986;60:161-171.
130. Zarins C, Giddens D, Bjaradvaj B, et al. Carotid bifurcation atherosclerosis: Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 1983;53:502-514.
131. Gibbons G, Dzau V. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431-1438.
132. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
133. Serruys P, De Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:490-495.
134. Mintz G, Pichard A, Kent K, et al. Endovascular stents reduce restenosis by eliminating geometric arterial remodeling: A serial intravascular ultrasound study. J Am Coll Cardiol 1995;25:36A.
135. The GUIDE Investigators. IVUS-determined predictors of restenosis in PTCA and DCA: An interim report from the GUIDE Trial, Phase II. Circulation 1994;90:I-23.